Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

N1 versus N2 and PMN‐MDSC: A critical appraisal of current concepts on tumor‐associated neutrophils and new directions for human oncology
Benedict Boateng Antuamwine, Rebeka Bosnjakovic, Francisca Hofmann‐Vega, et al.
Immunological Reviews (2022) Vol. 314, Iss. 1, pp. 250-279
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Myeloid-derived suppressor cells in cancer and cancer therapy
Samantha Lasser, Feyza Gül Özbay Kurt, Ihor Arkhypov, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 2, pp. 147-164
Closed Access | Times Cited: 116
Exploiting innate immunity for cancer immunotherapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 78
Cancer stem cells: advances in knowledge and implications for cancer therapy
Xianjing Chu, Wentao Tian, Jiaoyang Ning, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 73
The heterogeneity of neutrophils in cancer and its implication for therapeutic targeting
Evgeniy Eruslanov, Yulia Nefedova, Dmitry I. Gabrilovich
Nature Immunology (2025) Vol. 26, Iss. 1, pp. 17-28
Closed Access | Times Cited: 2
Targeting neutrophils: Mechanism and advances in cancer therapy
Shuaixi Yang, Jiachi Jia, Fuqi Wang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 14
Consensus, debate, and prospective on pancreatic cancer treatments
Junke Wang, Jie Yang, Amol Narang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 11
Neutrophils in glioma microenvironment: from immune function to immunotherapy
Chao Sun, Siwen Wang, Zhen Ma, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Neutrophil heterogeneity and plasticity: unveiling the multifaceted roles in health and disease
Weifeng He, Lingfeng Yan, Dongxue Hu, et al.
MedComm (2025) Vol. 6, Iss. 2
Open Access | Times Cited: 1
Exploring Neutrophil Heterogeneity and Plasticity in Health and Disease
Conny Gysemans, Mateson Beya, E.A. Pedace, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 597-597
Open Access | Times Cited: 1
NETosis: Sculpting tumor metastasis and immunotherapy
Yanyan Hu, Houhong Wang, Yang Liu
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 263-279
Open Access | Times Cited: 16
A novel tumor-associated neutrophil gene signature for predicting prognosis, tumor immune microenvironment, and therapeutic response in breast cancer
Jianyou Zhang, Xinbo Wang, Zhonglai Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Recent developments in myeloid immune modulation in cancer therapy
Sepideh Parvanian, Xinying Ge, Christopher Garris
Trends in cancer (2025)
Closed Access
Glucose Metabolism Reprogramming of Immune Cells in the Microenvironment of Pancreatic and Hepatobiliary Cancers
Yongqing Zhao, Weixiong Zhu, Shi Dong, et al.
Journal of Gastroenterology and Hepatology (2025)
Closed Access
Neutrophils: From Inflammatory Bowel Disease to Colitis-Associated Colorectal Cancer
Tianyi Chen, Jiachen Liu, Ruyi Hang, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 925-947
Open Access
IL-8 contributes to functional diversity of tumor-infiltrating neutrophils: A new target for cancer immunotherapy
Ece Tavukçuoğlu, Güneş Esendağlı
Developmental Cell (2025) Vol. 60, Iss. 3, pp. 339-341
Closed Access
Clinical significance of the tumor microenvironment on immune tolerance in gastric cancer
Xiangyang He, Xin‐Yuan Guan, Yan Li
Frontiers in Immunology (2025) Vol. 16
Open Access
Efficacy Assessment and Prognostic Value of Inflammatory Markers in Patients with Stage IV Acral and Cutaneous Melanoma Receiving PD-1 Inhibitors
Yan Zhang, Ziting Qu, Hau Xuan Nguyen, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 2531-2544
Open Access
Geranyl hydroquinone alleviates rheumatoid arthritis-associated pain by suppressing neutrophil accumulation, N1 polarization and ROS production in mice
Shiew‐Mei Huang, Yuxin Xie, Zhao‐Chun Zhan, et al.
Redox Biology (2025), pp. 103603-103603
Open Access
A comprehensive review on targeting diverse immune cells for anticancer therapy: beyond immune checkpoint inhibitors
Dequan Liu, Lei Liu, Xinming Zhao, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 210, pp. 104702-104702
Open Access
Prognostic significance of cytotoxic-T-lymphocytes to immunosuppressive lymphocytes ratio (CIL) in laryngeal squamous cell carcinoma
Duo Zhang, Yu Heng, Qing Jin, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 5
Open Access
Tumor cells that resist neutrophil anticancer cytotoxicity acquire a prometastatic and innate immune escape phenotype
Jagoda Szlachetko, Francisca Hofmann-Vega, Bettina Budeus, et al.
Cellular and Molecular Immunology (2025)
Open Access
Large-scale bulk and single-cell RNA sequencing combined with machine learning reveals glioblastoma-associated neutrophil heterogeneity and establishes a VEGFA+ neutrophil prognostic model
Yufan Yang, Ziyuan Liu, Zhongliang Wang, et al.
Biology Direct (2025) Vol. 20, Iss. 1
Open Access
TRAIL induces cytokine production via the NFkB2 pathway promoting neutrophil chemotaxis and neutrophil-mediated immune-suppression in triple negative breast cancer cells
Manjari Kundu, Yoshimi Endo Greer, Alexei Lobanov, et al.
Cancer Letters (2025), pp. 217692-217692
Closed Access
MYO1F in neutrophils is required for the response to immune checkpoint blockade therapy
Yingying Qu, Wenhua Liang, Mingzhu Yu, et al.
The Journal of Experimental Medicine (2025) Vol. 222, Iss. 6
Closed Access
Natural killer cells: the immune frontline against circulating tumor cells
Doryan Masmoudi, Martín Villalba, Catherine Alix‐Panabières
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top